Literature DB >> 32785791

Oropharyngeal Swallowing Dynamic Findings in People with Asthma.

Renata D'Arc Scarpel1, Ana Caline Nóbrega2, Patrícia Pinho3, Ivina Thaiana de Almeida Menezes3, Adelmir Souza-Machado4.   

Abstract

Airflow obstruction in people with asthma, similar to COPD, may interfere with swallowing, increasing the risk of food or liquid entrance into the lower airways, and favoring the uncontrolled disease. To describe the complaints and findings of the oropharyngeal swallowing mechanisms in patients with mild and severe asthma, a cross-sectional study was performed. A total of 135 participants with asthma were studied, of whom 97 had severe asthma and 38 had mild asthma. All subjects answered a questionnaire with demographic information, disease exacerbations, Asthma Control Questionnaire 6 (ACQ6-Juniper 1999), GastroEsophageal Reflux Disease Symptoms Questionnaire (GERD-SQ-Fornari et al. 2004), and Eating Assessment Tool 10 (EAT-10-Gonçalves et al., 2013). The oral and pharyngeal swallowing assessment occurred via videofluoroscopic swallowing evaluation. The age range of the participants was from 19 to 80 years, with a predominance of females (78.6%). Uncontrolled asthma was observed in 50 (52%) of the patients with severe asthma and in 11 (29%) of the patients with mild asthma (ACQ6 > 1.5). The GERD-SQ and EAT-10 scores were similar in both groups. In the bivariate analysis, the group with severe asthma presented with more changes when compared to the group with mild asthma in the following events: atypical lingual movement during the swallowing of liquid in the volumes of 5 ml (p = 0.003) and 10 ml (p = 0.001), and solid (p = 0.009); oral transit time increased in swallowing of liquid in the volumes of 5 ml (p = 0.003) and 20 ml (p = 0.026); beginning of the pharyngeal swallowing phase below the mandibular ramus (p = 0.003); pharyngeal residue (p = 0.017) of solid consistency; laryngeal penetration of 5 ml (p = 0.050) and 20 ml (p = 0.032) of liquid; increased transition time between the oral and pharyngeal swallowing phases (p = 0.035) and increased pharyngeal transit time (p = 0.045) of solid consistency. Tracheal aspiration was observed only in the group with severe asthma. After the multivariate analysis, atypical tongue movement maintained a statistically significant difference between the two groups. Oropharyngeal swallowing alternations were frequent in the studied sample and more markedly present in patients with severe asthma. Multivariate regression revealed atypical lingual movement, which was greater in patients with severe asthma. The clinical significance of these findings should be further investigated.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Asthma; Deglutition disorders; Dysphagia; Respiratory diseases; Swallowing

Year:  2020        PMID: 32785791     DOI: 10.1007/s00455-020-10168-1

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  32 in total

1.  Development and validation of a questionnaire to measure asthma control.

Authors:  E F Juniper; P M O'Byrne; G H Guyatt; P J Ferrie; D R King
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

2.  Oropharyngeal dysfunction in COPD patients: the need for clinical research.

Authors:  Susan M Harding
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

3.  Lung volume effects on pharyngeal swallowing physiology.

Authors:  Roxann Diez Gross; Charles W Atwood; Judith P Grayhack; Susan Shaiman
Journal:  J Appl Physiol (1985)       Date:  2003-08-08

4.  Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

Authors:  Ana Maria B Menezes; Maria Montes de Oca; Rogelio Pérez-Padilla; Gilbert Nadeau; Fernando César Wehrmeister; Maria Victorina Lopez-Varela; Adriana Muiño; José Roberto B Jardim; Gonzalo Valdivia; Carlos Tálamo
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

5.  Severe asthma and asthma-COPD overlap: a double agent or identical twins?

Authors:  Yang Xia; Yuan Cao; Lexin Xia; Wen Li; Huahao Shen
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

6.  [Symptom's questionnaire for gastroesophageal reflux disease].

Authors:  Fernando Fornari; Antônio Carlos Gruber; Antônio de Barros Lopes; Dileta Cecchetti; Sérgio Gabriel Silva de Barros
Journal:  Arq Gastroenterol       Date:  2005-03-29

7.  Validation of the videofluoroscopic dysphagia scale in various etiologies.

Authors:  Juyong Kim; Byung-Mo Oh; Jung Yoon Kim; Goo Joo Lee; Seung Ah Lee; Tai Ryoon Han
Journal:  Dysphagia       Date:  2014-08       Impact factor: 3.438

8.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

Authors:  Wendy C Moore; Deborah A Meyers; Sally E Wenzel; W Gerald Teague; Huashi Li; Xingnan Li; Ralph D'Agostino; Mario Castro; Douglas Curran-Everett; Anne M Fitzpatrick; Benjamin Gaston; Nizar N Jarjour; Ronald Sorkness; William J Calhoun; Kian Fan Chung; Suzy A A Comhair; Raed A Dweik; Elliot Israel; Stephen P Peters; William W Busse; Serpil C Erzurum; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2009-11-05       Impact factor: 21.405

9.  Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia.

Authors:  Lana Pikus; Marc S Levine; Yu-Xiao Yang; Stephen E Rubesin; David A Katzka; Igor Laufer; Warren B Gefter
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

10.  Oral and pharyngeal bolus transit in patients with chronic obstructive pulmonary disease.

Authors:  Rachel Aguiar Cassiani; Carla Manfredi Santos; José Baddini-Martinez; Roberto Oliveira Dantas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-05
View more
  1 in total

1.  Dysphagia in non-intubated patients affected by COVID-19 infection.

Authors:  Gianluigi Mariano Grilli; Rossana Giancaspro; Anna Del Colle; Carla Maria Irene Quarato; Donato Lacedonia; Maria Pia Foschino Barbaro; Michele Cassano
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-01       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.